A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential [Toxicological Sciences, April 2020]
/in Journal Publications /by Donna Troestler
504 S. Rosa Road, Suite 150
Madison, WI 53719
customerservice@stemina.com
Quick Links
Stemina’s neurological disorders business unit has developed a test to aid in the earlier diagnosis of autism spectrum disorder.